Content about Sato Pharmaceutical

May 7, 2013

Sato Pharmaceutical, maker of ZenTrip, an over-the-counter motion sickness remedy, recently completed an outdoor urban panel promotion with Duane Reade drug stores in New York, driving trial to the remedy’s thin-film medicated strip.

CARSON, Calif. — Sato Pharmaceutical, maker of ZenTrip, an over-the-counter motion sickness remedy, recently completed an outdoor urban panel promotion with Duane Reade drug stores in New York, driving trial to the remedy’s thin-film medicated strip.

Street-level displays were strategically placed throughout New York at subway entrances to reach multiple audiences with increased frequency, noted Russ Allison, Sato general manager U.S. 

June 21, 2012

The energy shot business in the mass market still is dominated by one player — Living Essentials’ 5-Hour Energy has almost 90% dollar share — but Sato Pharmaceutical, which boasts its Yunker Energy as the No. 1 energy shot in Japan, is looking to challenge that domination with the launch and support behind its Yunker Energy product across the United States.

CARSON, Calif. — The energy shot business in the mass market still is dominated by one player — Living Essentials’ 5-Hour Energy has almost 90% dollar share — but Sato Pharmaceutical, which boasts its Yunker Energy as the No. 1 energy shot in Japan, is looking to challenge that domination with the launch and support behind its Yunker Energy product across the United States. The overall category was up 9.3% to $194.5 million across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data.


August 18, 2011

Sato Pharmaceutical on Wednesday launched Zentrip, a new motion-sickness product featuring a fast-dissolving, fast-acting, citrus-flavored meclizine hydrochloride thin-strip.

TORRANCE, Calif. — Sato Pharmaceutical on Wednesday launched Zentrip, a new motion-sickness product featuring a fast-dissolving, fast-acting, citrus-flavored meclizine hydrochloride thin-strip.